TAI · 3054.TW
LIWANLI Innovation Co., Ltd.
NT$57.00-NT$0.50 (-0.87%)
LIWANLI Innovation Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.63% below the high.
Loading market information…
TWO · 6130.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Shangya Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shangya Technology Co., Ltd.’s forward annual dividend is NT$1.90 per share, paid annual. The forward yield is 8.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shangya Technology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Taipei, Taiwan, and established in 1994, Shangya Technology Co., Ltd. is a multifaceted enterprise with operations spanning several key sectors. The company primarily engages in the wholesale distribution of a diverse range of products within Taiwan, including traditional Chinese medicines, Western pharmaceuticals, medical equipment, weight-loss solutions, and beauty supplies. Beyond its distribution activities, Shangya Technology is also deeply involved in the design, development, manufacturing, and marketing of advanced integrated circuits (ICs). These include chips for wireless communication, satellite navigation systems, and various portable electronic devices. Additionally, the company extends its reach into the service industry, managing a network of beauty salons and providing a variety of other related offerings. Notably, the company underwent a name change in July 2023, adopting its current designation of Shangya Technology Co., Ltd., having previously operated as Singbao International Co. Ltd.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$57.00-NT$0.50 (-0.87%)
LIWANLI Innovation Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.63% below the high.
NT$23.95-NT$0.10 (-0.42%)
Allied Biotech Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.01% below the high.
NT$32.30-NT$1.10 (-3.29%)
Chunghwa Chemical Synthesis & Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.82% below the high.
NT$29.45NT$0.00 (0.0%)
Genomics BioSci & Tech. Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.08% below the high.
NT$28.50-NT$0.15 (-0.52%)
Chi Sheng Pharma & Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.92% below the high.
NT$23.00-NT$1.05 (-4.37%)
Advagene Biopharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.38% below the high.
NT$90.50NT$0.00 (0.0%)
Acer Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.3% below the high.
NT$17.60-NT$0.10 (-0.56%)
Arich Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.67% below the high.
